Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | N/A | N/A | N/A | 8,530 |
| Receivables | N/A | N/A | N/A | 350 |
| Other current assets | 0 | 0 | 0 | 470 |
| TOTAL | $N/A | $N/A | $N/A | $9,350 |
| Non-Current Assets | ||||
| PPE Net | N/A | N/A | N/A | 1,180 |
| Other Non-Current Assets | 0 | 0 | 0 | 120 |
| TOTAL | $N/A | $N/A | $N/A | $1,300 |
| Total Assets | $N/A | $N/A | $N/A | $9,880 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 760 |
| Accrued Expenses | N/A | N/A | N/A | 2,020 |
| Other current liabilities | N/A | N/A | N/A | 50 |
| TOTAL | $N/A | $N/A | $N/A | $14,430 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 570 |
| TOTAL | $N/A | $N/A | $N/A | $570 |
| Total Liabilities | $N/A | $N/A | $N/A | $16,410 |
| Shareholders' Equity | ||||
| Retained earnings | N/A | N/A | N/A | -44,620 |
| Other shareholders' equity | 0 | 0 | 0 | 32,220 |
| TOTAL | $N/A | $N/A | $N/A | $-6,530 |
| Total Liabilities And Equity | $0 | $0 | $0 | $9,880 |